Synonyms: example 3 [US20210276949]
Compound class:
Synthetic organic
Comment: The chemical structure for oveporexton was obtained from WHO proposed INN list 131 (August 2024). The INN record describes the compound as an orexin type 2 receptor agonist. Structure match in patents suggests that this might be the INN for Takeda's clinical lead TAK-861, as it is one of the examples claimed in patent US20210276949A1 [1].
|
|
Classification ![]() |
|
Compound class | Synthetic organic |
IUPAC Name ![]() |
N-[(2S,3R)-2-[[3-(3,5-difluorophenyl)-2-fluorophenyl]methyl]-4,4-difluoro-1-(2-hydroxy-2-methylpropanoyl)pyrrolidin-3-yl]ethanesulfonamide |
International Nonproprietary Names ![]() |
|
INN number | INN |
13257 | oveporexton |
Synonyms ![]() |
example 3 [US20210276949] |
Database Links ![]() |
|
CAS Registry No. | 2460722-04-5 (source: WHO INN record) |
GtoPdb PubChem SID | 500839923 |
PubChem CID | 154617563 |
Search Google for chemical match using the InChIKey | KVMGAIOTUIGROS-AZUAARDMSA-N |
Search Google for chemicals with the same backbone | KVMGAIOTUIGROS |
Search PubMed clinical trials | oveporexton |
Search PubMed titles | oveporexton |
Search PubMed titles/abstracts | oveporexton |
UniChem Compound Search for chemical match using the InChIKey | KVMGAIOTUIGROS-AZUAARDMSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | KVMGAIOTUIGROS-AZUAARDMSA-N |